Prescription Drug Pricing

David Axelrod
Health+Benefits David Axelrod
On the future of the ACA, prescription drugs, pollsters, and whether Mitch McCon...
January 20, 2021
The Compounding Business
Health+Benefits The Compounding Business
Q&A with Tara Thompson, Pharmacist and Vice President of Clinical Services at In...
January 19, 2021
Compounding Cost Savings
Health+Benefits Compounding Cost Savings
Q&A with Dhaval Bhanusali, MD, Dermatologist and Founder of Skin Medicinals
January 19, 2021
Runaway Freight Train
Health+Benefits Runaway Freight Train
Transparency alone isn’t enough to lower drug costs, but it’s a critical ste...
November 13, 2020
COVID-19 Solutions Fast-Tracked
Health+Benefits COVID-19 Solutions Fast-Tracked
Gilead relinquished its orphan drug status for remdesivir shortly after receivin...
May 31, 2020
Out of Reach?
Health+Benefits Out of Reach?
New models for financing and providing rare disease treatment could make for a s...
May 31, 2020
Parsing the Drug Supply Chain
Health+Benefits Parsing the Drug Supply Chain
Q&A with Eric Levin, CEO of Scripta Insights
April 27, 2020
PBGH Drug Formulary Study
Health+Benefits PBGH Drug Formulary Study
Q&A with Lauren Vela, Senior Director of Member Value, Pacific Business Group on...
March 1, 2020
Hospitals and Insurers Team Up to Manufacture Generic Drugs
Health+Benefits Hospitals and Insurers Team Up to Manufacture Generic Drugs
Unlikely advocates support lowering prescription drug costs
February 19, 2020
What Prescription Drug Importation Could Mean for Brokers
Health+Benefits What Prescription Drug Importation Could Mean for Brokers
Q&A with David Shore, SVP, Enterprise Strategy & Risk Management at Borislow Ins...
August 14, 2019